Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Colomer

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Acta Neurologica Scandinavica|March 1, 1986
Cranial CT scan in transient global amnesiaJ Matias-Guiu, R Colomer, A Segura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cellsJ A Menendez, S Ropero, R Lupu, et al.
Medicina Clinica|September 27, 1986
[Serum CA 15.3 in women with non-tumor breast pathologies. Initial results]A Ruibal, R Colomer, J M Gris, et al.
Journal of the National Cancer Institute|September 18, 1996
Recall reaction of a severe local peripheral neuropathy after paclitaxel extravasationM Hidalgo, J Benito, R Colomer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1992
Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responsesR Lupu, R Colomer, B Kannan, et al.
Cancer Investigation|April 9, 2001
Herceptin: from the bench to the clinicR Colomer, L A Shamon, M S Tsai, et al.
British Journal of Cancer|April 15, 2004
Cancer care in rural areasR Colomer, J R Germà, R Rosell, et al.
British Journal of Cancer|November 1, 1994
erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplificationR Colomer, R Lupu, S S Bacus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Circulating antigen levels in ovarian cancerR Colomer, J Genollà, J M del Campo, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Should prophylactic surgery be used in women with a high risk of breast cancer?J G Klijn, N Janin, H Cortés-Funes, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Acta Neurologica Scandinavica|March 1, 1986
Cranial CT scan in transient global amnesiaJ Matias-Guiu, R Colomer, A Segura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cellsJ A Menendez, S Ropero, R Lupu, et al.
Medicina Clinica|September 27, 1986
[Serum CA 15.3 in women with non-tumor breast pathologies. Initial results]A Ruibal, R Colomer, J M Gris, et al.
Journal of the National Cancer Institute|September 18, 1996
Recall reaction of a severe local peripheral neuropathy after paclitaxel extravasationM Hidalgo, J Benito, R Colomer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1992
Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responsesR Lupu, R Colomer, B Kannan, et al.
Cancer Investigation|April 9, 2001
Herceptin: from the bench to the clinicR Colomer, L A Shamon, M S Tsai, et al.
British Journal of Cancer|April 15, 2004
Cancer care in rural areasR Colomer, J R Germà, R Rosell, et al.
British Journal of Cancer|November 1, 1994
erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplificationR Colomer, R Lupu, S S Bacus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Circulating antigen levels in ovarian cancerR Colomer, J Genollà, J M del Campo, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Should prophylactic surgery be used in women with a high risk of breast cancer?J G Klijn, N Janin, H Cortés-Funes, et al.
Pageof 10